Hennessy Advisors Inc Abb Vie Inc. Transaction History

Hennessy Advisors Inc

$3.05 Billion
Q3 2024

A detailed history of Hennessy Advisors Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Hennessy Advisors Inc holds 31,200 shares of ABBV stock, worth $5.48 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

31,200

Previous 31,200 -0.0%

Holding current value

$5.48 Million

Previous $5.35 Million 15.14%

% of portfolio

0.2%

Previous 0.21%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$154.79 - $180.76 $108,353 - $126,532	-700 Reduced 2.19%	31,200 $5.35 Million
Q1 2024 Apr 15, 2024	BUY	$159.82 - $182.1 $5.1 Million - $5.81 Million	31,900 New	31,900 $5.81 Million
Q4 2023 Jan 18, 2024	SELL	$137.6 - $154.97 $233,920 - $263,449	-1,700 Reduced 5.23%	30,800 $4.77 Million
Q3 2023 Oct 18, 2023	SELL	$133.59 - $154.65 $93,513 - $108,255	-700 Reduced 2.11%	32,500 $4.84 Million
Q2 2023 Jul 17, 2023	SELL	$132.51 - $164.9 $251,768 - $313,310	-1,900 Reduced 5.41%	33,200 $4.47 Million
Q1 2023 Apr 14, 2023	SELL	$144.61 - $166.54 $2.81 Million - $3.23 Million	-19,400 Reduced 35.6%	35,100 $5.59 Million
Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $248,958 - $298,566	-1,800 Reduced 3.2%	54,500 $8.81 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $55,048 - $69,984	-400 Reduced 0.71%	56,300 $8.62 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $1.15 Million - $1.42 Million	-8,700 Reduced 13.3%	56,700 $9.19 Million
Q4 2021 Jan 25, 2022	SELL	$107.43 - $135.93 $214,860 - $271,860	-2,000 Reduced 2.97%	65,400 $8.86 Million
Q3 2021 Oct 12, 2021	SELL	$106.4 - $120.78 $117,040 - $132,858	-1,100 Reduced 1.61%	67,400 $7.27 Million
Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $52,605 - $58,605	500 Added 0.74%	68,500 $7.72 Million
Q1 2021 Apr 19, 2021	BUY	$102.3 - $112.62 $2.02 Million - $2.22 Million	19,700 Added 40.79%	68,000 $7.36 Million
Q4 2020 Jan 25, 2021	SELL	$80.49 - $108.67 $233,420 - $315,143	-2,900 Reduced 5.66%	48,300 $5.18 Million
Q3 2020 Oct 16, 2020	SELL	$85.91 - $100.83 $103,092 - $120,996	-1,200 Reduced 2.29%	51,200 $4.49 Million
Q2 2020 Jul 20, 2020	SELL	$73.37 - $98.18 $66,033 - $88,362	-900 Reduced 1.69%	52,400 $5.15 Million
Q1 2020 Apr 14, 2020	SELL	$64.5 - $97.79 $367,650 - $557,403	-5,700 Reduced 9.66%	53,300 $4.06 Million
Q4 2019 Jan 14, 2020	SELL	$72.13 - $90.25 $201,964 - $252,700	-2,800 Reduced 4.53%	59,000 $5.22 Million
Q3 2019 Oct 07, 2019	SELL	$62.98 - $75.72 $107,066 - $128,724	-1,700 Reduced 2.68%	61,800 $4.68 Million
Q1 2019 Apr 08, 2019	BUY	$77.14 - $90.79 $4.9 Million - $5.77 Million	63,500 New	63,500 $5.12 Million
Q1 2018 May 02, 2018	SELL	$92.01 - $123.21 $10.8 Million - $14.5 Million	-117,400 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$69.85 - $89.22 $8.2 Million - $10.5 Million	117,400	117,400 $10.4 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennessy Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hennessy Advisors Inc with notifications on news.

Account

Hennessy Advisors Inc Abb Vie Inc. Transaction History